Duration of antimicrobial therapy for non-typhoid Salmonella bacteremia in healthy children

Meng Hsin Yen, Yhu Chering Huang, Cheng Hsun Chiu, Tzou Yien Lin

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Medical records of patients less than 17 years of age with positive blood culture for non-typhoid Salmonella from June 1996 through December 1998 at the Chang Gung Children's Hospital were collected. Patients were categorized into 3 groups according to the duration of effective antibiotic therapy they received. Group 1 received effective antibiotic therapy for less than 7 days; Group 2 for 7 to 9 days; and Group 3 for 10 days or more. Information on clinical presentations, laboratory data, and outcome were collected and analyzed. A total of 59 children were eligible, with 21 in Group 1, 17 in Group 2, and 21 in Group 3. Demographic data were similar among the 3 groups. No significant difference was found in the clinical symptoms and laboratory data among these groups, including white blood cell count, immature to total ratio of white blood cell, and serum C-reactive protein level. Salmonella group B (n = 37) were the most common isolates, followed by group D (n = 9), group C2 (n = 8), cholerasuis (n = 4), and C1 (n = 2). Third-generation cephalosporins were the final antibiotic therapy in most (90%) patients, and no isolates showed resistance to these agents in this study. No focal suppurative complications were noted at the initial evaluation and in the 1-year period after treatment. No clinical recurrent diseases were noted during a follow-up period of at least 1 year. Results suggest that for otherwise healthy children with non-typhoid Salmonella bacteremia, less than 10 days of antibiotics therapy could be adequate if they are more than 1 year old and no focal extra-intestinal infection is noted in the initial evaluation.

Original languageEnglish
Pages (from-to)94-98
Number of pages5
JournalJournal of Microbiology, Immunology and Infection
Volume35
Issue number2
Publication statusPublished - 2002
Externally publishedYes

Fingerprint

Bacteremia
Salmonella
Anti-Bacterial Agents
Therapeutics
Cephalosporins
Leukocyte Count
C-Reactive Protein
Medical Records
Blood Proteins
Leukocytes
Demography
Infection
Serum

Keywords

  • Focal suppurative complication
  • Non-typhoid Salmonella bacteremia
  • Third-generation cephalosporins

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology and Microbiology(all)
  • Microbiology (medical)
  • Infectious Diseases

Cite this

Duration of antimicrobial therapy for non-typhoid Salmonella bacteremia in healthy children. / Yen, Meng Hsin; Huang, Yhu Chering; Chiu, Cheng Hsun; Lin, Tzou Yien.

In: Journal of Microbiology, Immunology and Infection, Vol. 35, No. 2, 2002, p. 94-98.

Research output: Contribution to journalArticle

@article{ee64fa6c44e54eb9b893738abd2ad37e,
title = "Duration of antimicrobial therapy for non-typhoid Salmonella bacteremia in healthy children",
abstract = "Medical records of patients less than 17 years of age with positive blood culture for non-typhoid Salmonella from June 1996 through December 1998 at the Chang Gung Children's Hospital were collected. Patients were categorized into 3 groups according to the duration of effective antibiotic therapy they received. Group 1 received effective antibiotic therapy for less than 7 days; Group 2 for 7 to 9 days; and Group 3 for 10 days or more. Information on clinical presentations, laboratory data, and outcome were collected and analyzed. A total of 59 children were eligible, with 21 in Group 1, 17 in Group 2, and 21 in Group 3. Demographic data were similar among the 3 groups. No significant difference was found in the clinical symptoms and laboratory data among these groups, including white blood cell count, immature to total ratio of white blood cell, and serum C-reactive protein level. Salmonella group B (n = 37) were the most common isolates, followed by group D (n = 9), group C2 (n = 8), cholerasuis (n = 4), and C1 (n = 2). Third-generation cephalosporins were the final antibiotic therapy in most (90{\%}) patients, and no isolates showed resistance to these agents in this study. No focal suppurative complications were noted at the initial evaluation and in the 1-year period after treatment. No clinical recurrent diseases were noted during a follow-up period of at least 1 year. Results suggest that for otherwise healthy children with non-typhoid Salmonella bacteremia, less than 10 days of antibiotics therapy could be adequate if they are more than 1 year old and no focal extra-intestinal infection is noted in the initial evaluation.",
keywords = "Focal suppurative complication, Non-typhoid Salmonella bacteremia, Third-generation cephalosporins",
author = "Yen, {Meng Hsin} and Huang, {Yhu Chering} and Chiu, {Cheng Hsun} and Lin, {Tzou Yien}",
year = "2002",
language = "English",
volume = "35",
pages = "94--98",
journal = "Journal of Microbiology, Immunology and Infection",
issn = "0253-2662",
publisher = "Elsevier Taiwan LLC",
number = "2",

}

TY - JOUR

T1 - Duration of antimicrobial therapy for non-typhoid Salmonella bacteremia in healthy children

AU - Yen, Meng Hsin

AU - Huang, Yhu Chering

AU - Chiu, Cheng Hsun

AU - Lin, Tzou Yien

PY - 2002

Y1 - 2002

N2 - Medical records of patients less than 17 years of age with positive blood culture for non-typhoid Salmonella from June 1996 through December 1998 at the Chang Gung Children's Hospital were collected. Patients were categorized into 3 groups according to the duration of effective antibiotic therapy they received. Group 1 received effective antibiotic therapy for less than 7 days; Group 2 for 7 to 9 days; and Group 3 for 10 days or more. Information on clinical presentations, laboratory data, and outcome were collected and analyzed. A total of 59 children were eligible, with 21 in Group 1, 17 in Group 2, and 21 in Group 3. Demographic data were similar among the 3 groups. No significant difference was found in the clinical symptoms and laboratory data among these groups, including white blood cell count, immature to total ratio of white blood cell, and serum C-reactive protein level. Salmonella group B (n = 37) were the most common isolates, followed by group D (n = 9), group C2 (n = 8), cholerasuis (n = 4), and C1 (n = 2). Third-generation cephalosporins were the final antibiotic therapy in most (90%) patients, and no isolates showed resistance to these agents in this study. No focal suppurative complications were noted at the initial evaluation and in the 1-year period after treatment. No clinical recurrent diseases were noted during a follow-up period of at least 1 year. Results suggest that for otherwise healthy children with non-typhoid Salmonella bacteremia, less than 10 days of antibiotics therapy could be adequate if they are more than 1 year old and no focal extra-intestinal infection is noted in the initial evaluation.

AB - Medical records of patients less than 17 years of age with positive blood culture for non-typhoid Salmonella from June 1996 through December 1998 at the Chang Gung Children's Hospital were collected. Patients were categorized into 3 groups according to the duration of effective antibiotic therapy they received. Group 1 received effective antibiotic therapy for less than 7 days; Group 2 for 7 to 9 days; and Group 3 for 10 days or more. Information on clinical presentations, laboratory data, and outcome were collected and analyzed. A total of 59 children were eligible, with 21 in Group 1, 17 in Group 2, and 21 in Group 3. Demographic data were similar among the 3 groups. No significant difference was found in the clinical symptoms and laboratory data among these groups, including white blood cell count, immature to total ratio of white blood cell, and serum C-reactive protein level. Salmonella group B (n = 37) were the most common isolates, followed by group D (n = 9), group C2 (n = 8), cholerasuis (n = 4), and C1 (n = 2). Third-generation cephalosporins were the final antibiotic therapy in most (90%) patients, and no isolates showed resistance to these agents in this study. No focal suppurative complications were noted at the initial evaluation and in the 1-year period after treatment. No clinical recurrent diseases were noted during a follow-up period of at least 1 year. Results suggest that for otherwise healthy children with non-typhoid Salmonella bacteremia, less than 10 days of antibiotics therapy could be adequate if they are more than 1 year old and no focal extra-intestinal infection is noted in the initial evaluation.

KW - Focal suppurative complication

KW - Non-typhoid Salmonella bacteremia

KW - Third-generation cephalosporins

UR - http://www.scopus.com/inward/record.url?scp=0035998402&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035998402&partnerID=8YFLogxK

M3 - Article

VL - 35

SP - 94

EP - 98

JO - Journal of Microbiology, Immunology and Infection

JF - Journal of Microbiology, Immunology and Infection

SN - 0253-2662

IS - 2

ER -